Published in Am J Gastroenterol on December 01, 1993
Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol (2005) 1.71
Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut (1997) 1.22
Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology (2010) 1.20
Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A (2003) 1.19
Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut (1997) 1.13
Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease:an overview. World J Gastroenterol (2000) 0.91
Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders. Dig Dis Sci (2003) 0.86
Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. J Clin Pathol (2005) 0.85
H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci (1999) 0.83
Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations. Korean J Intern Med (1999) 0.81
Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance. Dig Dis Sci (2005) 0.80
Time series analysis of gastric acid secretion over a 20-year period in normal Japanese men. J Gastroenterol (2014) 0.79
Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors? Dig Dis Sci (2000) 0.77
Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. World J Gastroenterol (2015) 0.77
Distinct effects of tetragastrin in rat gastroduodenal mucosa on mucin content and mucosal protective action against histamine-induced injury. Dig Dis Sci (1998) 0.76
Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury. Clin Transl Gastroenterol (2013) 0.75
Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol (2015) 0.75
Acid hypersecretion in duodenal ulcer patients. Am J Gastroenterol (1994) 0.75
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients. Dig Dis Sci (2003) 0.75
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77
Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 9.31
New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature (1995) 5.91
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science (1986) 5.86
Norwalk virus genome cloning and characterization. Science (1990) 5.83
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab (1982) 5.60
The role of macrophages in the induction of antibody in x-irradiated animals. Immunology (1967) 5.36
Early haemo-diafiltration in meningococcal septicaemia. Lancet (1996) 5.35
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol (1998) 4.46
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40
Sequence elimination and cytosine methylation are rapid and reproducible responses of the genome to wide hybridization and allopolyploidy in wheat. Plant Cell (2001) 4.38
Allopolyploidy-induced rapid genome evolution in the wheat (Aegilops-Triticum) group. Plant Cell (2001) 4.35
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
BVA policy on farm animal welfare. Vet Rec (1991) 4.25
Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun (1979) 4.24
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet (1992) 3.85
Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology (1998) 3.81
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry (1997) 3.71
A type VII myosin encoded by the mouse deafness gene shaker-1. Nature (1995) 3.71
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (1994) 3.70
Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage. Arch Intern Med (1992) 3.68
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57
Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect Immun (1977) 3.57
In vitro production of choleragen and vascular permeability factor by Vibrio cholerae. J Bacteriol (1968) 3.52
HTLV-III in cells cultured from semen of two patients with AIDS. Science (1984) 3.47
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
Prevention of thrombosis after pelvic surgery by British dextran 70. Lancet (1972) 3.28
Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20
N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16
Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Guidelines for radiologically guided lung biopsy. Thorax (2003) 2.91
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet (1997) 2.88
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Rapid genomic changes in newly synthesized amphiploids of Triticum and Aegilops. II. Changes in low-copy coding DNA sequences. Genome (1998) 2.81
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
Mechanical closure of the vocal cords with the laryngeal mask airway ProSeal. Br J Anaesth (2002) 2.74
Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67
The effect of chromosomes 5B, 5D, and 5A on chromosomal pairing in triticum aestivum. Proc Natl Acad Sci U S A (1966) 2.66
A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63
Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med (1987) 2.61
Somatic association in Triticum aestivum. Proc Natl Acad Sci U S A (1966) 2.61
Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60
Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54
Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology (1999) 2.51
Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature (1985) 2.48
Rotavirus stability and inactivation. J Gen Virol (1979) 2.48
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47
Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47
Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med (1985) 2.46
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44
Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43
Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med (1983) 2.40
Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun (2000) 2.40
Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet (1997) 2.40
Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun (1996) 2.40
Community leg ulcer clinics: a comparative study in two health authorities. BMJ (1996) 2.40
Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39